Equities

MedAdvisor Ltd

MedAdvisor Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)0.295
  • Today's Change-0.005 / -1.67%
  • Shares traded685.87k
  • 1 Year change+68.57%
  • Beta0.6161
Data delayed at least 20 minutes, as of Nov 18 2024 04:54 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year MedAdvisor Ltd grew revenues 24.64% from 97.96m to 122.11m while net income improved from a loss of 11.31m to a gain of 792.13k.
Gross margin60.81%
Net profit margin0.65%
Operating margin0.76%
Return on assets0.81%
Return on equity1.58%
Return on investment1.37%
More ▼

Cash flow in AUDView more

In 2024, MedAdvisor Ltd increased its cash reserves by 9.72%, or 1.38m. The company earned 5.19m from its operations for a Cash Flow Margin of 4.25%. In addition the company used 2.80m on investing activities and also paid 831.97k in financing cash flows.
Cash flow per share0.0091
Price/Cash flow per share33.16
Book value per share0.0937
Tangible book value per share-0.0241
More ▼

Balance sheet in AUDView more

MedAdvisor Ltd has a Debt to Total Capital ratio of 19.64%, a lower figure than the previous year's 25.40%.
Current ratio0.7119
Quick ratio--
Total debt/total equity0.2444
Total debt/total capital0.1964
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.